Journal
LEUKEMIA & LYMPHOMA
Volume 56, Issue 4, Pages 1107-1114Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/10428194.2014.947612
Keywords
alpha v beta 3; integrin; myeloma; thyroid hormone
Categories
Funding
- Li Ka Sling Foundation (LKSF)
Ask authors/readers for more resources
Thyroid hormones (T-3 and T-4) induce proliferation in multiple myeloma (MM) cell lines via the alpha v beta 3 integrin-mitogen-activated protein kinase (MAPK) pathway. We further show in primary MM bone marrow (BM) samples (n = 9) induction of cell viability by 1 nM T-3 (13%, p < 0.002) and more potently by 100 nM T-4 (21-45%, p < 0.0002) and a quick (1 h) and long-lasting (24 h) pERK activation, which was inhibited in the presence of beta 3 but not beta 1 blocking antibodies. Involvement of the integrin was further shown by two disintegrins, Arg-Gly-Asp (RGD) and echistatin peptides, which occluded the effects of T-3/T-4 on viability, proliferating cell nuclear antigen (PCNA) (proliferation marker) and apoptotic gene expression. Lastly, T-3/T-4 significantly opposed bortezomib (25 nM) cytotoxicy, as confirmed by several methods. In summary, our results imply that endogenous thyroid hormones in myeloma are factors that may support cell growth, with relevance to bortezomib action.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available